{"nct_id":"NCT00813956","title":"A Phase 2 Study of Standard Chemotherapy Plus BSI-201 (a PARP Inhibitor) in the Neoadjuvant Treatment of Triple Negative Breast Cancer","status":"COMPLETED","status_verified_date":"2016-02","start_date":"2008-12","start_date_type":null,"primary_completion_date":"2012-10","primary_completion_date_type":"ACTUAL","completion_date":"2012-10","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["SNY"]}